DIABETIC KIDNEY DISEASE
Clinical trials for DIABETIC KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new DIABETIC KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for DIABETIC KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a vitamin-like pill slow kidney damage in diabetes?
Disease control Recruiting nowThis study tests whether a supplement called NMN can improve kidney health in people with type 2 diabetes and diabetic kidney disease. About 156 adults will take either NMN or a placebo twice daily for 6 months. The main goal is to see if NMN reduces a key marker of kidney damage…
Matched conditions: DIABETIC KIDNEY DISEASE
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 26, 2026 08:56 UTC
-
Pharmacists to the rescue: new study lets them prescribe Kidney-Saving drugs
Disease control Recruiting nowThis study tests whether community pharmacists can safely prescribe medications that protect the kidneys in people with type 2 diabetes and early kidney disease. About 120 adults without a family doctor will be randomly assigned to either pharmacist-led care using a step-by-step …
Matched conditions: DIABETIC KIDNEY DISEASE
Phase: NA • Sponsor: Nova Scotia Health Authority • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
Could an asthma drug protect kidneys in diabetes?
Disease control Recruiting nowThis study tests whether formoterol, a drug typically used for asthma, can help people with diabetic kidney disease. About 120 adults with type 2 diabetes and moderate kidney damage will be randomly assigned to receive either formoterol plus their usual care or usual care alone. …
Matched conditions: DIABETIC KIDNEY DISEASE
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
New pill could slow kidney disease in diabetes patients
Disease control Recruiting nowThis study tests if a new drug called R3R01 can lower protein in the urine, a sign of kidney damage, in adults with type 2 diabetes and kidney disease. About 60 people will take either R3R01 or a placebo for 3 months. Researchers will check urine protein, kidney function, and blo…
Matched conditions: DIABETIC KIDNEY DISEASE
Phase: PHASE2 • Sponsor: River 3 Renal Corp. • Aim: Disease control
Last updated May 18, 2026 12:00 UTC
-
New pill for diabetic kidney disease enters early human testing
Disease control Recruiting nowThis early-stage study tests a new oral medication called AP303 in 18 adults with diabetic kidney disease. The main goals are to check the drug's safety and how the body handles it over two weeks. Participants will be randomly assigned to receive either AP303 or a placebo, and ne…
Matched conditions: DIABETIC KIDNEY DISEASE
Phase: PHASE1 • Sponsor: Alebund Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
New study aims to uncover hidden kidney damage in diabetes patients
Knowledge-focused Recruiting nowThis study looks at 300 people with type 2 diabetes who have high levels of protein in their urine, a sign of kidney trouble. Researchers will take small kidney samples (biopsies) and analyze blood, urine, and genetic data to find patterns that help diagnose diabetic kidney disea…
Matched conditions: DIABETIC KIDNEY DISEASE
Sponsor: Herlev Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 08:34 UTC
-
New MRI method could replace needles for kidney disease monitoring
Knowledge-focused Recruiting nowThis study tests whether special MRI scans can help diagnose and track diabetic kidney disease (DKD) without needles or biopsies. About 150 adults with DKD will get MRI scans and regular check-ups over 6 months. The goal is to see if MRI can predict how fast kidney function decli…
Matched conditions: DIABETIC KIDNEY DISEASE
Sponsor: Shengjing Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 08:19 UTC
-
New drug MTX-439 enters first human safety tests for diabetic kidney disease
Knowledge-focused Recruiting nowThis early-phase study tests the safety of a new drug called MTX-439 in healthy adults and people with diabetic kidney disease. Researchers will give single or multiple doses to see how the body handles the drug and what side effects occur. The study does not aim to treat the dis…
Matched conditions: DIABETIC KIDNEY DISEASE
Phase: PHASE1 • Sponsor: Mediar Therapeutics • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC